Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LANTRONIX INCLTRX · Entity 1667 | Chief Technology Officer | August 29, 2017 | August 31, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LANTRONIX INC
Report date August 29, 2017 · Filed August 31, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.16 · Expires 2024-08-29 | Direct | 70,000 |
Reported balance
After 2017-08-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-08-29 · Grant · Acquired 70,000 · Balance 70,000 F1: The option vests according to the following schedule: 25% of the option (17,500 shares) vests on the first anniversary of the grant date and the remainder of the option (52,500 shares) shall vest ratably each month thereafter over a period of 36 months. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests according to the following schedule: 25% of the option (17,500 shares) vests on the first anniversary of the grant date and the remainder of the option (52,500 shares) shall vest ratably each month thereafter over a period of 36 months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 29, 2017 Filed Aug 31, 2017 20:30 UTC | LANTRONIX INC LTRX · Entity 1667 | GrantStock Option (Right to buy) · Derivative | 70,000 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001683168-17-002276 · datla_frm4.xml · derivative · entry 1 Datla Sanjeev · CIK 0001666531 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2024-08-29 F1 · derivative.exercise_date: The option vests according to the following schedule: 25% of the option (17,500 shares) vests on the first anniversary of the grant date and the remainder of the option (52,500 shares) shall vest ratably each month thereafter over a period of 36 months. Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:30 UTC | LANTRONIX INC LTRX · Entity 1667 | OtherCommon Stock | 5,883 | $1.06 | $6,250.69 |
DisclosureSEC source: 0001683168-17-001318 · datla_frm4.xml · nonDerivative · entry 1 Datla Sanjeev · CIK 0001666531 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,426 F1 · kind: Represent shares of common stock acquired through the Lantronix, Inc. 2013 Employee Stock Purchase Plan. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 21:30 UTC | LANTRONIX INC LTRX · Entity 1667 | OtherCommon Stock | 6,543 | $1.06 | $6,951.94 |
DisclosureSEC source: 0001683168-16-000702 · datla_frm4.xml · nonDerivative · entry 1 Datla Sanjeev · CIK 0001666531 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,543 F1 · kind: Represent shares of common stock acquired through the Lantronix, Inc. 2013 Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.